Low Risk of Failing Direct-Acting Antivirals in People With Human Immunodeficiency Virus/Hepatitis C Virus From Sub-Saharan Africa or Southeastern Asia: A European Cross-Sectional Study.
Cas J IsfordinkAnders BoydAmanda MocroftKatharina KusejkoColette SmitStephane de WitTabitha MahunguKarolin FalconerGilles WandelerMatthias CavassiniMarcel StöckleJanke SchinkelAndri RauchLars PetersMarc van der Valknull nullPublished in: Open forum infectious diseases (2022)
rates were high in individuals with HIV/HCV residing in Europe and originating from regions where intrinsically NS5A-resistant HCV strains are endemic. HCV elimination for this population in Europe is unlikely to be hampered by suboptimal DAA efficacy.